SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-039653
Filing Date
2022-02-14
Accepted
2022-02-14 08:12:03
Documents
13
Period of Report
2022-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d298220d8k.htm   iXBRL 8-K 24843
2 EX-99.1 d298220dex991.htm EX-99.1 88464
  Complete submission text file 0001193125-22-039653.txt   241900

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20220214.xsd EX-101.SCH 2893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20220214_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20220214_pre.xml EX-101.PRE 10837
7 EXTRACTED XBRL INSTANCE DOCUMENT d298220d8k_htm.xml XML 3212
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 22625445
SIC: 2834 Pharmaceutical Preparations